Find Research Outputs

Search in all content

Filters for Research Output

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2016

Author

  • David S Miller
2020

An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275

Schink, J. C., Filiaci, V., Huang, H. Q., Tidy, J., Winter, M., Carter, J., Anderson, N., Moxley, K., Yabuno, A., Taylor, S. E., Kushnir, C., Horowitz, N. & Miller, D. S., Aug 2020, In : Gynecologic oncology. 158, 2, p. 354-360 7 p.

Research output: Contribution to journalReview article

Open Access
9 Scopus citations

Bridging Radiation Therapy Before Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed or Refractory Aggressive B-Cell Lymphoma

Wright, C. M., LaRiviere, M. J., Baron, J. A., Uche, C., Xiao, Y., Arscott, W. T., Anstadt, E. J., Barsky, A. R., Miller, D., LaRose, M. I., Landsburg, D. J., Svoboda, J., Nasta, S. D., Gerson, J. N., Barta, S. K., Chong, E. A., Schuster, S. J., Paydar, I., Maity, A. & Plastaras, J. P., Sep 1 2020, In : International Journal of Radiation Oncology Biology Physics. 108, 1, p. 178-188 11 p.

Research output: Contribution to journalArticle

2 Scopus citations
Open Access

Overexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group Study

Krill, L., Deng, W., Eskander, R., Mutch, D., Zweizig, S., Hoang, B., Ioffe, O., Randall, L., Lankes, H., Miller, D. S. & Birrer, M., Feb 2020, In : Gynecologic oncology. 156, 2, p. 423-429 7 p.

Research output: Contribution to journalArticle

2 Scopus citations

Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery

Mullany, S., Miller, D. S., Robison, K., Levinson, K., Lee, Y. C., Yamada, S. D., Walker, J., Markman, M., Marin, A., Mast, P. & diZerega, G., Nov 2020, In : Gynecologic Oncology Reports. 34, 100627.

Research output: Contribution to journalArticle

Open Access
Open Access

Progress in endometrial cancer: Contributions of the former Gynecologic Oncology Group

Miller, D. S., Randall, M. E. & Filiaci, V., May 2020, In : Gynecologic oncology. 157, 2, p. 312-322 11 p.

Research output: Contribution to journalShort survey

1 Scopus citations

Second-line lenvatinib in patients with recurrent endometrial cancer

Vergote, I., Powell, M. A., Teneriello, M. G., Miller, D. S., Garcia, A. A., Mikheeva, O. N., Bidzinski, M., Cebotaru, C. L., Dutcus, C. E., Ren, M., Kadowaki, T., Funahashi, Y. & Penson, R. T., Mar 2020, In : Gynecologic oncology. 156, 3, p. 575-582 8 p.

Research output: Contribution to journalArticle

Open Access
2019

Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer

Matei, D., Filiaci, V., Randall, M. E., Mutch, D., Steinhoff, M. M., DiSilvestro, P. A., Moxley, K. M., Kim, Y. M., Powell, M. A., O’Malley, D. M., Spirtos, N. M., Small, W., Tewari, K. S., Richards, W. E., Nakayama, J., Matulonis, U. A., Huang, H. Q. & Miller, D. S., Jun 13 2019, In : New England Journal of Medicine. 380, 24, p. 2317-2326 10 p.

Research output: Contribution to journalArticle

63 Scopus citations
8 Scopus citations

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

Moore, K. N., Secord, A. A., Geller, M. A., Miller, D. S., Cloven, N., Fleming, G. F., Wahner Hendrickson, A. E., Azodi, M., DiSilvestro, P., Oza, A. M., Cristea, M., Berek, J. S., Chan, J. K., Rimel, B. J., Matei, D. E., Li, Y., Sun, K., Luptakova, K., Matulonis, U. A. & Monk, B. J., May 2019, In : The Lancet Oncology. 20, 5, p. 636-648 13 p.

Research output: Contribution to journalArticle

63 Scopus citations

Phase III trial: Adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel/ carboplatin in high-intermediate and high-risk early stage endometrial cancer

Randall, M. E., Filiaci, V., McMeekin, D. S., Von Gruenigen, V., Huang, H., Yashar, C. M., Mannel, R. S., Kim, J. W., Salani, R., DiSilvestro, P. A., Burke, J. J., Rutherford, T., Spirtos, N. M., Terada, K., Anderson, P. R., Brewster, W. R., Small, W., Aghajanian, C. A. & Miller, D. S., Jul 20 2019, In : Journal of Clinical Oncology. 37, 21, p. 1810-1818 9 p.

Research output: Contribution to journalArticle

48 Scopus citations

Reply to F. Tomao et al

Hensley, M. L., Enserro, D. & Miller, D. S., Jan 1 2019, In : Journal of Clinical Oncology. 37, 11, 1 p.

Research output: Contribution to journalLetter

The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncology Group (GOG) study

Spirtos, N. M., Enserro, D., Homesley, H. D., Gibbons, S. K., Cella, D., Morris, R. T., DeGeest, K., Lee, R. B. & Miller, D. S., Jul 2019, In : Gynecologic oncology. 154, 1, p. 13-21 9 p.

Research output: Contribution to journalArticle

1 Scopus citations

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

TRINOVA-3/ENGOT-ov2/GOG-3001 investigators, Jun 2019, In : The Lancet Oncology. 20, 6, p. 862-876 15 p.

Research output: Contribution to journalArticle

10 Scopus citations
2018

Adenocarcinoma of the uterine corpus

Creasman, W. T. & Miller, D. S., Jan 1 2018, Clinical Gynecologic Oncology. Elsevier Inc., p. 121-154.e8

Research output: Chapter in Book/Report/Conference proceedingChapter

Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for high-grade uterine leiomyosarcoma: A phase III NRG oncology/gynecologic oncology group study

Hensley, M. L., Enserro, D., Hatcher, H., Ottevanger, P. B., Krarup-Hansen, A., Blay, J. Y., Fisher, C., Moxley, K. M., Lele, S. B., Lea, J. S., Tewari, K. S., Thaker, P. H., Zivanovic, O., O'Malley, D. M., Robison, K. & Miller, D. S., Nov 20 2018, In : Journal of Clinical Oncology. 36, 33, p. 3324-3330 7 p.

Research output: Contribution to journalArticle

27 Scopus citations
2 Scopus citations

Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study

Felix, A. S., Brasky, T. M., Cohn, D. E., Mutch, D. G., Creasman, W. T., Thaker, P. H., Walker, J. L., Moore, R. G., Lele, S. B., Guntupalli, S. R., Downs, L. S., Nagel, C., Boggess, J. F., Pearl, M. L., Ioffe, O. B., Deng, W., Miller, D. S. & Brinton, L. A., Mar 15 2018, In : International Journal of Cancer. 142, 6, p. 1102-1115 14 p.

Research output: Contribution to journalArticle

4 Scopus citations

Hypoalbuminemia is a Predictive Factor for Fistula Formation in Recurrent Cervical Cancer

Palavalli Parsons, L. H., Roane, B., Manders, D. B., Richardson, D. L., Kehoe, S. M., Carlson, M., Miller, D. S. & Lea, J. S., Oct 1 2018, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 10, p. 933-937 5 p.

Research output: Contribution to journalArticle

2 Scopus citations
3 Scopus citations

Pre-operative core muscle index in combination with hypoalbuminemia is associated with poor prognosis in advanced ovarian cancer

Conrad, L. B., Awdeh, H., Acosta-Torres, S., Conrad, S. A., Bailey, A. A., Miller, D. S. & Lea, J. S., Jan 1 2018, (Accepted/In press) In : Journal of Surgical Oncology.

Research output: Contribution to journalArticle

9 Scopus citations

Prognostic Significance of Nodal Location and Ratio in Stage IIIC Endometrial Carcinoma among a Multi-Institutional Academic Collaboration

Mayadev, J., Elshaikh, M. A., Christie, A., Nagel, C., Kennedy, V., Khan, N., Lea, J. S., Ghanem, A., Miller, D. S., Xie, X-J., Folkert, M. R. & Albuquerque, K., Dec 1 2018, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 12, p. 1220-1224 5 p.

Research output: Contribution to journalArticle

2 Scopus citations
6 Scopus citations
2016

Factors influencing primary treatment of midline vulvar cancers

Conrad, L. B., Conrad, S. A., Miller, D. S., Richardson, D. L., Kehoe, S. & Lea, J. S., Mar 6 2016, (Accepted/In press) In : Gynecologic Oncology.

Research output: Contribution to journalArticle

Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis

Moore, K. N., Java, J. J., Slaughter, K. N., Rose, P. G., Lanciano, R., DiSilvestro, P. A., Thigpen, J. T., Lee, Y. C., Tewari, K. S., Chino, J., Seward, S. M., Miller, D. S., Salani, R., Moore, D. H. & Stehman, F. B., Nov 1 2016, In : Gynecologic oncology. 143, 2, p. 294-301 8 p.

Research output: Contribution to journalArticle

20 Scopus citations

Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia

Osborne, R. J., Filiaci, V. L., Schink, J. C., Mannel, R. S., Behbakht, K., Hoffman, J. S., Spirtos, N. M., Chan, J. K., Tidy, J. A. & Miller, D. S., Sep 1 2016, In : Obstetrics and gynecology. 128, 3, p. 535-542 8 p.

Research output: Contribution to journalArticle

20 Scopus citations

Sparse feature selection for classification and prediction of metastasis in endometrial cancer

Ahsen, M. E., Boren, T. P., Singh, N. K., Misganaw, B., Lea, J. S., Miller, D. S., White, M. A. & Vidyasagar, M., Oct 2 2016, ACM-BCB 2016 - 7th ACM Conference on Bioinformatics, Computational Biology, and Health Informatics. Association for Computing Machinery, Inc, p. 522-524 3 p.

Research output: Chapter in Book/Report/Conference proceedingConference contribution